Real-world outcomes by race in patients (pts) with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Final analysis results from the informCLL registry.

被引：0
|
作者：
Barrientos, Jacqueline Claudia
Sharman, Jeff Porter
Gutierrez, Meghan E.
Wu, Linda
Qureshi, Zaina P.
Raz, Anat
Girardi, Vincent
Naganuma, Maoko
Ghosh, Nilanjan
机构：
[1] Mt Sinai Comprehens Canc Ctr, Miami Beach, FL USA
[2] US Oncol Res, Willamette Valley Canc Inst & Res Ctr, Eugene, OR USA
[3] Lymphoma Res Fdn, New York, NY USA
[4] Janssen, Horsham, PA USA
[5] Janssen Sci Affairs LLC, Horsham, PA USA
[6] Pharmacyclics LLC, San Francisco, CA USA
[7] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7536
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Integrated and Long-Term Safety Analysis of Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 13 - 14
  • [42] Characteristics of patients treated for CLL in a real-world registry: results from informCLL™
    Mato, Anthony
    Sharman, Jeff
    Pagel, John
    Brander, Danielle
    Kadish, Karen
    Tomlinson, Brian
    Ipe, David
    Yang, Huiying
    Arango-Hisijara, Israel
    Srivastava, Bhavini
    Schenkel, Brad
    Barrientos, Jacqueline
    LEUKEMIA & LYMPHOMA, 2017, 58 : 48 - 49
  • [43] Prognostic Testing and Treatment Approaches in Patients with Chronic Lymphocytic Leukemia: Clinical Experience from an Interim Analysis of the informCLL™ Real-World Registry
    Mato, Anthony R.
    Barrientos, Jacqueline C.
    Brander, Danielle M.
    Pagel, John M.
    Gutierrez, Meghan
    Kadish, Karen
    Tomlinson, Brian
    Ghosh, Nilanjan
    Giafis, Nick
    Ipe, David
    Upasani, Sandhya
    Sundaram, Murali
    Ferrante, Lucille
    Amaya-Chanaga, Carlos
    Iyengar, Reethi
    Sharman, Jeff
    BLOOD, 2018, 132
  • [44] Is Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) a Lymphoma of Mantle Zone B-Cells?
    Tandon, B.
    Swerdlow, S. H.
    Hasserjian, R. P.
    Gibson, S. E.
    MODERN PATHOLOGY, 2013, 26 : 364A - 364A
  • [45] Is Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) a Lymphoma of Mantle Zone B-Cells?
    Tandon, B.
    Swerdlow, S. H.
    Hasserjian, R. P.
    Gibson, S. E.
    LABORATORY INVESTIGATION, 2013, 93 : 364A - 364A
  • [46] Real-world duration of venetoclax treatment for chronic lymphocytic leukemia and small lymphocytic lymphoma
    Teschemaker, Anna
    Hakre, Shweta
    Tse, Jenny
    Shaikh, Nazneen Fatima
    Gu, Yifan
    Near, Aimee
    LEUKEMIA & LYMPHOMA, 2023, 64 : S62 - S63
  • [47] A Real-World Study of Zanubrutinib Treatment in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
    Zhu, Huayuan
    Xia, Yi
    Miao, Yi
    Qin, Shuchao
    Wu, Wei
    Qiu, Tonglu
    Wang, Li
    Fan, Lei
    Xu, Wei
    Li, Jianyong
    BLOOD, 2023, 142
  • [48] Real-World Clinical Outcomes of First-Line (1L) Ibrutinib Dose Reduction Versus Acalabrutinib Among Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
    Shadman, Mazyar
    Karve, Sudeep
    Abbazio, Christopher
    Majd, Zahra
    Bacchus, Shaffee
    Saifan, Chadi
    Gogna, Priyanka
    Manceur, Ameur M.
    Lafeuille, Marie-Helene
    Emond, Bruno
    Srivastava, Bhavini P.
    Stephens, Deborah M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S352 - S352
  • [49] Retrospective Analysis of Real-World Outcomes of Chronic/ Small Lymphocytic Leukemia (CLL/SLL) Patients Treated With First-Line Ibrutinib Versus Chemoimmunotherapy (CIT)
    Ran, Tao
    He, Jinghua
    Wu, Linda
    Panjabi, Sumeet
    Lu, Xiaoxiao
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S275 - S276
  • [50] Pathology Quiz Case 1 Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) of the LDS
    Van Abel, Kathryn M.
    Bilyk, Jurij R.
    Bourne, Scott E.
    Ezzat, Waleed H.
    Finden, Steven G.
    Pribitkin, Edmund A.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2010, 136 (10) : 1037 - +
12345